News | Stroke | September 28, 2017

Majority of High-Risk Stroke Patients Not Being Screened for Common Risk Factors

New research identifies significant gaps between recommended guidelines and clinical practice for stroke prevention across 20 countries

Majority of High-Risk Stroke Patients Not Being Screened for Common Risk Factors

September 28, 2017 — New research revealed that on average, more than 75 percent of people aged 65 and older worldwide are not being screened for atrial fibrillation (AF) and other common stroke risk factors during routine primary care examinations, even though this population is at high risk for stroke.

The “Preventing Stroke: Uneven Progress Report,” released by The Economist Intelligence Unit (EIU), a division of The Economist and sponsored by The Bristol-Myers Squibb-Pfizer Alliance, conducted an analysis of 20 countries and found that efforts to screen people for stroke risk factors including AF and hypertension varied widely, even in countries with established healthcare and developed economies.

“Stroke is the second leading cause of death globally, accounting for 6.2 million deaths,1 but is nearly 80 percent preventable,”2 said Becca Lipman, editor of the EIU’s thought leadership division and of this report. “Our hope is that this research will elevate the awareness and urgency surrounding screening for stroke risk factors including AF and hypertension and offer suggestions on what can be done on a country-by-country level to further improve prevention. There are critical and urgent opportunities to improve screening, so that fewer people suffer the devastating consequences of stroke.”

The report considered policy efforts to assess and reduce risks of stroke across different aspects including awareness, screening practices and policies. Key findings include:

  • There is a disconnect between established best practices and everyday clinical practice. For example, there are gaps in the training of healthcare professionals to properly identify and treat stroke risks;
  • Screening for AF and hypertension remains low and is not regularly performed in clinical practice; and
  • Future policies should focus on strategies to improve awareness of stroke risk factors, implement systematic and/or opportunistic screenings, and include both individual and population-based health-intervention approaches.

“People with AF are at least three times more likely to have a stroke than those without this condition,”3,4,5 said Rory O’Connor, M.D., chief medical officer, Pfizer Internal Medicine. “Even modest improvements in diagnosis and treatment of stroke risk factors including AF – supported by collaborations across healthcare providers, advocates, policymakers and the private sector – could potentially prevent many strokes and related deaths.”6

The EIU developed a scorecard to assess each country’s performance across four different categories and conducted in-depth interviews with experts on cardiovascular health and stroke, which were included in the final report.

For more information:


1. Top 10 Causes of Death. (webpage) World Health Organization. Accessed on August 10, 2017.
2. Myth vs. Fact: Stroke Facts (webpage). National Stroke Association. Accessed on August 10, 2017.
3. January, C. T. (2014). ACC/AHA/HRS Guideline for the Management of Patients with Atrial Fibrillation. Circulation, 130, E212-E212. doi:10.1161/CIR.0000000000000041/-/DC1.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22: 983–8.
5. Spodato LA, Cipriano LE, Saposnik G. (2015). Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 377–87.
6. Stroke Facts. The U.S. Centers for Disease Control and Prevention (CDC). (webpage) Accessed on August 10, 2017.
7. Ben Freedman, Tatjana S. Potpara, and Gregory Y H Lip, "Stroke prevention in atrial fibrillation," The Lancet 388, no. 10046 (2016): , doi:10.1016/s0140-6736(16)31257-0.

Related Content

Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Overlay Init